Cargando…

A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19

INTRODUCTION: Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) swept rapidly throughout the world. So far, no therapeutics have yet proven to be effective. Ribavirin was recommended for the treatment of COVID-19 in China because of its in vit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Wei-Jing, Zhou, Tao, Wu, San-Lan, Ye, Jia-Long, Xu, Jia-Qiang, Zeng, Fang, Su, Yu-Yong, Han, Yong, Lv, Yong-Ning, Zhang, Yu, Cai, Xue-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894089/ https://www.ncbi.nlm.nih.gov/pubmed/33676844 http://dx.doi.org/10.1016/j.jiac.2021.02.018

Ejemplares similares

Ribavirin therapy for severe COVID-19: a retrospective cohort study
por: Tong, Song, et al.
Publicado: (2020)

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Gong, Wei-Jing, et al.
Publicado: (2021)

Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome
por: Lau, Eric H.Y., et al.
Publicado: (2009)

Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study
por: Li, Hui, et al.
Publicado: (2021)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Clinical efficacy of immunoglobulin on the treatment of severe fever with thrombocytopenia syndrome: a retrospective cohort study
por: Zhang, Shan-Shan, et al.
Publicado: (2023)

Efficacy of ribavirin against malignant glioma cell lines
por: OGINO, AKIYOSHI, et al.
Publicado: (2014)

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
por: Mayor, Jennifer, et al.
Publicado: (2021)

A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
por: Hung, Hsuan-Yu, et al.
Publicado: (2021)

The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients
por: Li, Qiang, et al.
Publicado: (2021)

In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus
por: Lee, Myung Jin, et al.
Publicado: (2017)

Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China
por: Wu, Qin, et al.
Publicado: (2015)

Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
por: Cho, Hyun Chin, et al.
Publicado: (2013)

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
por: Manfredi, Roberto, et al.
Publicado: (2010)

Case report: Ribavirin and vitamin A in a severe case of measles
por: Bichon, Amandine, et al.
Publicado: (2017)

Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
por: Hwang, Yong, et al.
Publicado: (2015)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
por: Gallacher, Jennifer, et al.
Publicado: (2023)

Comparative Bioavailability and Tolerability of Single and Multiple Doses of 2 Diclofenac Sodium Sustained-Release Tablet Formulations in Fasting, Healthy Chinese Male Volunteers()
por: Zhai, Xue-Jia, et al.
Publicado: (2013)

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
por: Omrani, Ali S, et al.
Publicado: (2014)

Use of saliva flow rate measurement in minor salivary glands autotransplantation for treatment of severe dry eye disease
por: Su, Jia-Zeng, et al.
Publicado: (2022)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Relationship between Post-Stroke Cognitive Impairment and Severe Dysphagia: A Retrospective Cohort Study
por: Qiao, Jia, et al.
Publicado: (2022)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

Efficacy of ribavirin against malignant glioma cell lines: Follow-up study
por: Ochiai, Yushi, et al.
Publicado: (2018)

Case–Control Study on Prednisolone Combined With Ursodeoxycholic Acid and Azathioprine in Pure Primary Biliary Cirrhosis With High Levels of Immunoglobulin G and Transaminases: Efficacy and Safety Analysis
por: Fang, Yu-Qing, et al.
Publicado: (2014)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
por: Suii, Hirokazu, et al.
Publicado: (2017)

Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection
por: Shimojima, Masayuki, et al.
Publicado: (2015)

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
por: Yu, Ming-Lung, et al.
Publicado: (2012)

Effects of glycine 64 substitutions in RNA-dependent RNA polymerase on ribavirin sensitivity and pathogenicity of coxsackievirus A6
por: Wang, Rui, et al.
Publicado: (2023)

Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis
por: He, Qiu-Feng, et al.
Publicado: (2016)

Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever
por: Salehi, Hassan, et al.
Publicado: (2013)

Clinical characteristics of severe influenza virus-associated pneumonia complicated with bacterial infection in children: a retrospective analysis
por: Wang, Qiong-yu, et al.
Publicado: (2023)

Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
por: Lee, Tae-Hee, et al.
Publicado: (2014)

Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study
por: Su, Ning, et al.
Publicado: (2022)

Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro
por: Anderson, John F., et al.
Publicado: (2002)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q16g9q7smmsh49lo9tc5mgc8hp